JTJiro Takeuchi

Jiro Takeuchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jiro Takeuchi has a total of 131 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex-specific associations between annual kidney function changes and weight/waist changes in overweight Japanese: Japan Specific Health Checkup cohort

    by Naoki Ozu, Jiro Takeuchi, Kiyoshi Asada, Kunihiro Yamagata, Kunitoshi Iseki, Toshiki Moriyama, Kazuhiko Tsuruya, Shouichi Fujimoto, Ichiei Narita, Tsuneo Konta, et al.

    The impact of changes in obesity-related parameters on kidney functions is unclear. To evaluate the association of body weight (BW) and waist circumference (WC) changes with estimated glomerular filtration rate (eGFR) and proteinuria in obese individuals, we conducted retrospective analysis of the Japan Specific Health Checkup cohort of 664,926 participants (Japanese residents aged 40–74 years) from 2008 to 2011. Participants were classified into nine groups based on BW and WC changes from baseline. Sex differences were stratified. Generalized estimating equations were used to evaluate eGFR changes within each group and the effect of BW or WC changes on eGFR. In a similar manner, the impact of BW and WC changes on the incidence of proteinuria was measured. As a result, total of 20,326 participants with a body mass index of ≥25 kg/m2 and available baseline data, 1-year BW and WC, and 4-year eGFR measurements were included in the analysis. The eGFR slope was –0.59 (95% confidence interval [CI], –0.66 to –0.51). At a threshold change of approximately 5%, compared to the group with unchanged BW and WC, males with decreased BW and WC had improved eGFR at 3 years (1.75; 95% CI, 0.49 to 3.02). Contrastingly, females with increased BW and WC had worsened eGFR at 3 years (–3.44; 95% CI, –6.40 to –0.47). These trends were similar when the thresholds were changed or when the outcome was proteinuria. In conclusion, males with decreasing WC and BW had improved kidney function. Future studies should evaluate specific lifestyle factors.

  • Initial Treatment Failure as a Predictor of Proximal Extension in Patients with Newly Diagnosed Limited Ulcerative Colitis: A Retrospective Cohort Study with Propensity Score-Matched Analysis

    by Toshiyuki Sato, Jiro Takeuchi, Kazuko Nagase, Tetsuya Shiraishi, Keiko Yokoyama, Soichi Yagi, Koji Kaku, Yasuhiro Takagi, Maiko Ikenouchi, Mikio Kawai, et al.

    Background Patients with ulcerative colitis (UC) frequently experience proximal extension during their disease course. Aims We examined whether initial treatment failure affects proximal extension in limited UC. Methods This retrospective cohort study comprised patients who were newly diagnosed with limited UC between April 2006 and March 2015. Initial treatment failure was defined as either no remission within 3 months of onset (no remission group) or remission followed by relapse within 3 months (early relapse group). Patients who maintained remission for > 3 months were included in the initial treatment success group. The primary outcome was the incidence of proximal extension. Secondary outcomes included colectomy, hospitalization, and refractoriness to medication. Propensity score matching (PSM) was performed to adjust for baseline differences. Results Of 229 eligible patients (median follow-up, 9.6 years), 68 (29.7%) developed proximal extension. Before PSM, initial treatment failure was significantly associated with proximal extension, and this association remained after PSM. In the overall cohort, multivariable Cox analysis confirmed initial treatment failure as an independent risk factor for proximal extension (adjusted hazard ratio 3.2; 95% confidence interval 1.9–5.3). The hospitalization rate was significantly higher in the initial treatment failure group than in the initial treatment success group after PSM. Conclusion Initial treatment failure is an independent prognostic factor for proximal extension in patients with limited UC and is associated with worse long-term outcomes. Careful monitoring and early therapeutic strategies may be warranted for patients with initial treatment failure.


  • Postmenstrual age at Extubation as a Risk Factor Associated With Respiratory‐Related Reintubation Among Extremely Preterm Infants: A Retrospective Cohort Study

    by Masanori Kambara, Jiro Takeuchi, Akari Kumano, Chisato Fujita, Mami Matsumura, Akiko Suzuki, Daishi Takao, Tomohiro Iseki, Akihiko Kai, Shu Maekawa, et al.

    Background: Previous studies that discussed risk factors associated with extubation failure among preterm infants may have underestimated extubation failures because they used short observation windows for detecting reintubations. Aims: To explore risk factors associated with reintubations among extremely preterm infants during hospitalization. Study Design: A single‐center, retrospective cohort study. Subjects: Infants born < 28 weeks gestational age between January 1, 2018, and December 31, 2022. Outcome Measures: We focused only on extubation failures associated with respiratory problems. We assessed risk factors by conducting multivariable logistic regression analyses using variables previously reported as risk factors associated with extubation failure among preterm infants. Results: Ninety‐five infants with a median gestational age of 25.6 weeks were eligible, and of those, 33 infants (34.7%) experienced extubation failure. Reintubations within 7 days after extubation accounted for approximately three‐quarters of whole reintubations (24 infants, 72.7%). Risk factors associated with extubation failure were partial pressure of carbon dioxide (PCO 2 ) before extubation (adjusted odds ratio [OR], 1.07; 95% confidence interval [CI], 1.01–1.14; p = 0.023), fraction of inspired oxygen (F I O 2 ) before extubation (adjusted OR, 2.97; 95% CI, 1.10–8.04; p = 0.032), and postmenstrual age (PMA) at extubation (adjusted OR, 0.90; 95% CI, 0.84–0.97; p = 0.004). The predictive model submitting these variables demonstrated an area under the curve of 0.802. Conclusions: When evaluating extubation failures more precisely by adopting the longer period, we might need to consider not only respiratory status before extubation but also maturity at extubation to assess extubation readiness.


  • Open Access

    Mumps vaccination and immune status among Japanese university students: A multicenter cross-sectional study

    by Jiro Takeuchi, Iwata Ozaki, Kokichi Hata, Manami Nozawa, Kanami Fukushima, Norio Fukumori, Mie Imanaka, Yuta Sakanishi, Masayuki Shima, Takeshi Morimoto

    Background: During the mumps outbreak in Japan in 2016, 159,031 cases were reported. In a survey conducted in 2015, mumps vaccination rates for the first dose were 30%–40%. However, the rates for two or more doses were not determined. We assessed the mumps vaccination rates and mumps infection prevalence according to vaccine doses received. Design and methods: This was a multicenter cross-sectional study. Students from three universities participated in 2019. Informed consent was obtained from the students and their guardians. The primary outcome was the prevalence of breakthrough mumps infection according to the number of doses of vaccine received. We collected data on past illnesses of vaccine-preventable diseases and vaccination history using a questionnaire, photocopies of the Maternal and Child Health Handbook from the guardians, and virus antibody titers from the universities’ health centers. Results: This study assessed 2004 eligible students and included 593 (29.6%); of these, 250 (42.7%) had a mumps infection history. Furthermore, 264 (44.6%), 31 (5.2%), and 2 (0.3%) students received the first, second, and third doses of mumps vaccine, respectively. The mumps seropositivity prevalence was 43.2% ( n = 127), 36.7% ( n = 97), 26.7% ( n = 8), and 100% ( n = 2) for the no-, first-, second-, and third-dose groups, respectively ( p for trend = 0.09). The mumps infection prevalence rates were 69.8% ( n = 203), 11.3% ( n = 28), 3.9% ( n = 1), and 0% for the no-, first-, second-, and third-dose groups, respectively. Conclusions: Approximately 1 in 10 students who had received only one dose of mumps-containing vaccine had a breakthrough infection history.


  • Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer

    by Yudai Hojo, Yoshinori Ishida, Toshihiko Tomita, Yasunori Kurahashi, Tatsuro Nakamura, Yoshitaka Kitayama, Eiichiro Nakao, Shugo Kohno, Motoki Murakami, Jiro Takeuchi, et al.


  • Open Access

    Association between administration or recommendation of the human papillomavirus vaccine and primary care physicians’ knowledge about vaccination during proactive recommendation suspension: a nationwide cross-sectional study in Japan

    by Yuta Sakanishi, Jiro Takeuchi, Rei Suganaga, Kuniko Nakayama, Yosuke Nishioka, Hiroshi Chiba, Tomomi Kishi, Ako Machino, Mami Mastumura, Tadao Okada, et al.

    Objective The Japanese government suspended the proactive recommendation of the human papillomavirus vaccine (HPVv) in 2013, and the vaccination rate of HPVv declined to Design Cross-sectional study analysed data obtained through a web-based, self-administered questionnaire survey. Setting The questionnaire was distributed to Japan Primary Care Association (JPCA) members. Participants JPCA members who were physicians and on the official JPCA mailing list (n=5395) were included. Primary and secondary outcome measures The primary and secondary outcomes were the administration and recommendation of HPVv, respectively, by PCPs. The association between PCPs’ knowledge regarding vaccination and each outcome was determined based on their background and vaccination quiz scores and a logistic regression analysis to estimate the adjusted ORs (AORs). Results We received responses from 1084 PCPs and included 981 of them in the analysis. PCPs with a higher score on the vaccination quiz were significantly more likely to administer the HPVv for routine and voluntary vaccination (AOR 2.28, 95% CI 1.58 to 3.28; AOR 2.71, 95% CI 1.81 to 4.04, respectively) and recommend the HPVv for routine and voluntary vaccination than PCPs with a lower score (AOR 2.17, 95% CI 1.62 to 2.92; AOR 1.88, 95% CI 1.32 to 2.67, respectively). Conclusions These results suggest that providing accurate knowledge regarding vaccination to PCPs may improve their administration and recommendation of HPVv, even in the absence of active government recommendations.


  • Open Access

    Adverse Events in Pediatric Inpatients: The Japan Adverse Event Study

    by Mio Sakuma, Yoshinori Ohta, Jiro Takeuchi, Yuki Yuza, Hiroyuki Ida, David W. Md Bates, Takeshi Morimoto

    Objectives: Adverse events (AEs) represent an important cause of morbidity and mortality for pediatric inpatients; however, reports on their epidemiology in pediatrics, especially outside Western countries, are scarce. We investigated the incidence and nature of AEs in pediatric inpatients in Japan. Methods: Trained pediatrician and pediatric nurses reviewed all medical documents of 1126 pediatric inpatients in 2 tertiary care teaching hospitals in Japan, and potential incidents were collected with patients’ characteristics. Age was categorized into 6 groups (neonates, infants, preschoolers, school-aged children, teenagers, and over-aged pediatric patients), and medical care when potential incidents occurred was classified into drug, operation, procedure/examinations, nursing, management, and judgment. Physician reviewers independently evaluated all collected incidents into AEs, potential AEs, medical errors, and exclusions and assessed their severity and preventability. Results: A total of 1126 patients with 12,624 patient-days were enrolled, and 953 AEs, with an incidence of 76 (95% confidence interval, 71–80) per 1000 patient-days, were identified. Preventable AEs accounted for 23% (218/953) of AEs. The incidence of AEs tended to decrease with increasing age. The proportion of AEs that were preventable was highest in neonates (40%), and this proportion decreased as children aged. Both judgment and management-related AEs were considered preventable AEs, and judgment-related AEs were more severe AEs than no-judgment–related AEs; 43% were life-threatening. Conclusions: Adverse events were common in Japanese pediatric inpatients, and their preventability and severity varied considerably by age category and medical care. Further investigation is needed to address which strategies might most improve pediatric patient safety.


  • Monitoring for adverse drug events of high-risk medications with a computerized clinical decision support system: a prospective cohort study

    by Mari Nezu, Mio Sakuma, Tsukasa Nakamura, Tomohiro Sonoyama, Chisa Matsumoto, Jiro Takeuchi, Yoshinori Ohta, Shinji Kosaka, Takeshi Morimoto

    Monitoring is recommended to prevent severe adverse drug events, but such examinations are often missed. To increase the number of monitoring that should be ordered for high-risk medications, we introduced a clinical decision support system (CDSS) that alerting and ordering the monitoring for high-risk medications in an outpatient setting. We conducted a 2-year prospective cohort study at a tertiary care teaching hospital before (phase 1) and after (phase 2) the activation of a CDSS. The CDSS automatically provided alerts for liver function tests for vildagliptin, thyroid function tests for immune checkpoint inhibitors (ICIs) and multikinase inhibitors (MKIs), and a slit-lamp examination of the eyes for oral amiodarone when outpatients were prescribed the medications but not examined for a fixed period. The order of laboratory tests was automatically appeared if alert was accepted. The alerts were hidden and did not appear on the display before activation of the CDSS. The outcomes were the number of prescriptions with alerts and examinations. During the study period, 330 patients in phase 1 and 307 patients in phase 2 were prescribed vildagliptin, 20 patients in phase 1 and 19 patients in phase 2 were prescribed ICIs or MKIs, and 72 patients in phase 1 and 66 patients in phase 2 were prescribed oral amiodarone. The baseline characteristics were similar between the phases. In patients prescribed vildagliptin, the proportion of alerts decreased significantly (38% vs 27%, PPPP=0.13). In patients prescribed oral amiodarone, the proportion of alerts decreased (86% vs 81%, P=0.055), and the proportion of examinations increased (2.2% and 3.0%, P=0.47); neither was significant. The CDSS has potential to increase the monitoring for high-risk medications. Our study also highlighted the limited acceptance rate of monitoring by CDSS. Further studies are needed to explore the generalizability to other medications and the cause of the limited acceptance rates among physicians.


  • Open Access

    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases

    by Kozo Kataoka, Kanae Takahashi, Jiro Takeuchi, Kazuma Ito, Naohito Beppu, Wim Ceelen, Yukihide Kanemitsu, Yoichi Ajioka, Itaru Endo, Kiyoshi Hasegawa, et al.

    Dear Editor

  • Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases

    by Kozo Kataoka, Kanae Takahashi, Jiro Takeuchi, Kazuma Ito, Naohito Beppu, Wim Ceelen, Yukihide Kanemitsu, Yoichi Ajioka, Itaru Endo, Kiyoshi Hasegawa, et al.

    Background: The role of recurrence-free survival (RFS) as a valid surrogate endpoint for overall survival (OS) in patients who underwent upfront surgery for colorectal liver metastases remains uncertain. The aim of the study was to compare the two survival measures in a nationwide cohort of upfront resected colorectal liver metastasis. Methods: Data from patients with colorectal liver metastases without extrahepatic metastases who underwent curative surgery for liver metastases were retrieved from the Japanese nationwide database (data collection 2005–2007 and 2013–2014). RFS, OS, and survival after recurrence were estimated using the Kaplan–Meier method. The correlation (ρ) between RFS and OS was assessed using the rank correlation method combined with iterative multiple imputation, to account for censoring. As a secondary analysis, the correlation was evaluated according to adjuvant chemotherapy regimen. In sensitivity analysis, the pairwise correlation between RFS and OS was calculated. Results: A total of 2385 patients with colorectal liver metastases were included. In the primary analysis, there was a moderately strong correlation between RFS and OS (ρ = 0.73, 95 per cent c.i. 0.70 to 0.76). The strength of the correlation was similar regardless of the adjuvant treatment regimen (oxaliplatin plus 5-fluorouracil: ρ = 0.72, 0.67 to 0.77; 5-fluorouracil alone: ρ = 0.72, 0.66 to 0.76; observation: ρ = 0.74, 0.69 to 0.78). The mean(s.d.) pairwise correlation coefficient between 3-year RFS and 5-year OS was 0.87(0.06). Conclusion: In surgically treated patients with colorectal liver metastases, there was a moderately strong correlation between RFS and OS, which was unaffected by the treatment regimen. Further validation using a trial-level analysis is required.